MNPR - What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? | Benzinga
Monopar Therapeutics Inc (NASDAQ:MNPR) shares jumped during the trading session on Thursday on a strong volume session volume of 16.179 million, compared to an average volume of 1.817 million, as per the data from Benzinga Pro.
Thursday, the company announced preclinical imaging and therapeutic efficacy data for its MNPR-101 radiopharmaceutical program, a radiopharma program that targets cancers expressing the urokinase plasminogen ...